Travi G, Pergam SA, Xie H, Carpenter P, Kiem HP, Corey L, Boeckh MJ
The Effect of Imatinib on Cytomegalovirus Reactivation in Hematopoietic Cell Transplantation. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Nov 3.
In vitro studies have shown possible antiviral effects of tyrosine kinase inhibitors. In a retrospective study, we show that use of the tyrosine kinase inhibitor imatinib does not appear to reduce cytomegalovirus reactivation during the first 100 days after transplantation in a cohort of hematopoietic cell transplant recipients.
More from this journal |
